Drugs

Rami Komrokji: Imetelstat approved for MDS patients

Photo from Rami Komrokji/Twitter

Jun 7, 2024, 12:04

Rami Komrokji: Imetelstat approved for MDS patients

Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Center, shared a post on X: .

“I am so honored to be part of this journey as a senior clinical investigator and having presented the data to the ODAC (Oncologic Drugs Advisory Committee) FDA committee to get Imetelstat approved to hopefully help many of our MDS (Myelodysplastic syndromes) patients.”

Read Further.
Source: Rami Komrokji/X

cancer FDA FDA ODAC imetelstat MDS Moffitt Cancer Center myelodysplastic syndromes ODAC OncoDaily Oncologic Drugs Advisory Committee Oncology Rami Komrokji

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage